257 related articles for article (PubMed ID: 10926385)
21. Designing clinical trials to evaluate mucus clearance therapy.
Rubin BK
Respir Care; 2007 Oct; 52(10):1348-58; discussion 1358-61. PubMed ID: 17894903
[TBL] [Abstract][Full Text] [Related]
22. Mucoactive drugs.
Balsamo R; Lanata L; Egan CG
Eur Respir Rev; 2010 Jun; 19(116):127-33. PubMed ID: 20956181
[TBL] [Abstract][Full Text] [Related]
23. Aerosolized Medications for Gene and Peptide Therapy.
Laube BL
Respir Care; 2015 Jun; 60(6):806-21; discussion 821-4. PubMed ID: 26070576
[TBL] [Abstract][Full Text] [Related]
24. Mucoactive agents for adults with acute lung conditions: A systematic review.
Tarrant BJ; Maitre CL; Romero L; Steward R; Button BM; Thompson BR; Holland AE
Heart Lung; 2019; 48(2):141-147. PubMed ID: 30409442
[TBL] [Abstract][Full Text] [Related]
25. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
Laube BL
Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
[TBL] [Abstract][Full Text] [Related]
26. Mucus structure and properties in cystic fibrosis.
Rubin BK
Paediatr Respir Rev; 2007 Mar; 8(1):4-7. PubMed ID: 17419972
[TBL] [Abstract][Full Text] [Related]
27. Physiology of airway mucus secretion and pathophysiology of hypersecretion.
Rogers DF
Respir Care; 2007 Sep; 52(9):1134-46; discussion 1146-9. PubMed ID: 17716382
[TBL] [Abstract][Full Text] [Related]
28. Erdosteine: Drug exhibiting polypharmacy for the treatment of respiratory diseases.
Dal Negro R; Pozzi E; Cella SG
Pulm Pharmacol Ther; 2018 Dec; 53():80-85. PubMed ID: 30352285
[TBL] [Abstract][Full Text] [Related]
29. Rheological profile of nesosteine: a new mucoactive agent.
Braga PC; Beghi G; Castelli C; Grasselli G; Ornaghi A; Rampoldi C; Zheng Y; Allegra L
Int J Clin Pharmacol Res; 1989; 9(1):77-83. PubMed ID: 2707929
[TBL] [Abstract][Full Text] [Related]
30. [Aerosols: a re-emerging treatment].
Diot P; Mallet JP; Lemarié E
Rev Pneumol Clin; 1998 Jul; 54(3):125-34. PubMed ID: 9769998
[TBL] [Abstract][Full Text] [Related]
31. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
[TBL] [Abstract][Full Text] [Related]
32. Plastic bronchitis as an unusual cause of mucus plugging in cystic fibrosis.
Mateos-Corral D; Cutz E; Solomon M; Ratjen F
Pediatr Pulmonol; 2009 Sep; 44(9):939-40. PubMed ID: 19658112
[TBL] [Abstract][Full Text] [Related]
33. Current and future therapies for airway mucus hypersecretion.
Barnes PJ
Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
[TBL] [Abstract][Full Text] [Related]
34. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
[TBL] [Abstract][Full Text] [Related]
35. [Inhalation therapy].
None LV; Lemarié E; Diot P
Rev Infirm; 2006 Feb; (118):16-23. PubMed ID: 16562547
[No Abstract] [Full Text] [Related]
36. [Inhalation therapy in chronic mucus retention].
Köhler D
Pneumologie; 1990 Oct; 44(10):1166-70. PubMed ID: 2281059
[No Abstract] [Full Text] [Related]
37. Mucoactive drugs and multiple applications in pulmonary disease therapy.
Hocquigny A; Hugerot H; Ghanem R; Haute T; Laurent V; Cogulet V; Montier T
Eur J Pharm Biopharm; 2024 Jan; 194():110-117. PubMed ID: 38048888
[TBL] [Abstract][Full Text] [Related]
38. Assessment of airway secretions by pulmonary function tests.
Demedts M
Eur J Respir Dis; 1987 Nov; 71(5):330-3. PubMed ID: 3327699
[No Abstract] [Full Text] [Related]
39. [Ambroxol].
Akkoca Yildiz O
Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
[No Abstract] [Full Text] [Related]
40. Management of mucus hypersecretion.
Clarke SW
Eur J Respir Dis Suppl; 1987; 153():136-44. PubMed ID: 3322858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]